In our study, 6 key genes, ALDH5A1, DVL3, NRCAM, RORC, PSMB9, and TNFRSF17, which play key roles in COAD, were identified, while the potential of these genes as drug targets needs to be further examined. This evidence concerns the gene NRCAM and colon adenocarcinoma.